Award ID: RP100708 Project Title: Development of a novel anti-EGFR antibody-protamine recombinant protein for in vivo delivery of small interfering RNAs for cancer therapy Award Mechanism: - Nimotuzumab - Document - PDFSEARCH.IO

First Page	Meta Content
	Award ID: RP100708 Project Title: Development of a novel anti-EGFR antibody-protamine recombinant protein for in vivo delivery of small interfering RNAs for cancer therapy Award Mechanism: Add to Reading List Document Date: 2014-11-20 01:49:16 Open Document File Size: 45,14 KB Share Result on Facebook Company CPRIT / / Facility University of Texas M.D. Anderson Cancer Center Lay Summary / / IndustryTerm cancer therapy / treatment of several types of human cancers / / MedicalCondition molecularly targeted cancer / head and neck cancer / targeted cancer / human cancers / kill cancer / cancer / / MedicalTreatment cancer therapy / / Organization University of Texas M.D. Anderson Cancer Center Lay Summary / / Person Zhen Entity / / Position High Impact/High Risk Principal Investigator / / Technology treating cancer / siRNA / antibodies / / SocialTag Drugs Targeted therapy Epidermal growth factor receptor Head and neck cancer Nimotuzumab Zalutumumab Medicine Biology Oncology

Award ID: RP100708 Project Title: Development of a novel anti-EGFR antibody-protamine recombinant protein for in vivo delivery of small interfering RNAs for cancer therapy Award Mechanism:Add to Reading List